BACK TO FUND'S DETAIL PAGE
All Holdings
All Holdings
176 Total Holdings:
As of 3/31/25
All Holdings:
1 -
15 of
176
| Security Name | Asset Type |
Shares or Principal Amount |
Market Value |
Percent of Net Assets 
|
|---|---|---|---|---|
| Microsoft Corp. | Equity | 15,209,984 | $5,709,675,894.00 | 5.58% |
| Capital Group Central Cash Fund | Short Term | 48,809,087 | $4,880,908,662.00 | 4.77% |
| RTX Corp. | Equity | 30,587,416 | $4,051,609,123.00 | 3.96% |
| AbbVie, Inc. | Equity | 15,483,326 | $3,244,066,464.00 | 3.17% |
| Apple, Inc. | Equity | 13,941,345 | $3,096,790,965.00 | 3.03% |
| General Electric Co. | Equity | 13,756,440 | $2,753,351,466.00 | 2.69% |
| UnitedHealth Group, Inc. | Equity | 4,695,922 | $2,459,489,148.00 | 2.4% |
| Broadcom, Inc. | Equity | 13,461,065 | $2,253,786,113.00 | 2.2% |
| JPMorgan Chase & Co. | Equity | 8,072,782 | $1,980,253,425.00 | 1.94% |
| Meta Platforms, Inc., Class A | Equity | 3,281,699 | $1,891,440,036.00 | 1.85% |
| Mondelez International, Inc., Class A | Equity | 27,588,648 | $1,871,889,767.00 | 1.83% |
| International Paper Co. | Equity | 34,785,973 | $1,855,831,660.00 | 1.81% |
| Abbott Laboratories | Equity | 13,729,526 | $1,821,221,624.00 | 1.78% |
| Philip Morris International, Inc. | Equity | 10,582,098 | $1,679,696,416.00 | 1.64% |
| Gilead Sciences, Inc. | Equity | 14,455,614 | $1,619,751,549.00 | 1.58% |
All Holdings:
1 -
15 of
176